Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody
Author:
Funder
National Institutes of Health
NIBIB U54
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://www.jci.org/articles/view/162282/files/pdf
Reference34 articles.
1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
3. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
4. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
5. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine models;Antiviral Research;2024-11
2. Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity;Vaccine;2024-10
3. Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants;npj Vaccines;2024-09-04
4. Cell surface RNA virus nucleocapsid proteins: a viral strategy for immunosuppression?;npj Viruses;2024-09-02
5. SARS-COV-2 breakthrough infection and its covariates among healthcare providers of a hospital in Bangladesh during the omicron wave;Heliyon;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3